Bifunctional chelators and conjugates
US-2024254092-A1 · Aug 1, 2024 · US
US9448225B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9448225-B2 |
| Application number | US-201314107732-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 16, 2013 |
| Priority date | Jan 30, 2009 |
| Publication date | Sep 20, 2016 |
| Grant date | Sep 20, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention provides a compound of formula (I): (wherein: R 1 is an optionally substituted 2-(1-azathiaxanthone); each —R 2 is independently of the formula —CH 2 —C(═O)—R 4 , wherein R 4 is an amino acid or a salt thereof, attached to the remainder of R 2 through the nitrogen atom of the amino group; and R 3 is hydrogen or a C 1-6 alkyl group); or (wherein: R 1 is an optionally substituted 2-(1-azaxanthone); each R 2 is independently an optionally substituted glutaric or succinic acid, or a salt or ester thereof; and R 3 is hydrogen or a C 1-6 alkyl group).
Opening claim text (preview).
The invention claimed is: 1. A compound of the following formula: wherein each -A is —CO 2 H, or a salt thereof; and R 3 is either hydrogen or methyl. 2. The compound of claim 1 , wherein R 3 is hydrogen. 3. The compound of claim 1 , wherein R 3 is methyl. 4. A complex comprising: a lanthanide (III) ion; and a compound of the following formula wherein each -A is —CO 2 H, or a salt thereof; and R 3 is either hydrogen or methyl. 5. The complex of claim 4 , wherein R 3 is hydrogen. 6. The complex of claim 4 , wherein R 3 is methyl. 7. The complex of claim 4 wherein the lanthanide (III) ion is europium (III) or terbium (III). 8. The complex of claim 4 wherein the lanthanide (III) ion is europium (III). 9. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 4 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 10. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 7 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 11. A method of analyzing lactate present in a sample of interest, the method comprising: (i) contacting the sample of interest with a complex as defined in claim 8 ; (ii) exciting the azaxanthone; and (iii) determining the quantity or concentration of any lactate in the sample of interest by analysis of the modulation in one or more emission bands resultant from the exciting where citrate is present. 12. A method of, or for use in, the diagnosis of excessive lactic acid comprising: (i) obtaining a liquid sample from a subject; (ii) optionally diluting the liquid sample; and (iii) practicing a method as defined in claim 9 , wherein the liquid sample or the diluted liquid sample constitutes the sample of interest. 13. The method of claim 12 wherein the liquid has been previously obtained from the subject.
of the prostate · CPC title
Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper {and including single- and multilayer analytical elements (immunological elements G01N33/54386; involving labelled immunochemicals G01N33/58; for haemoglobin or occult blood G01N33/72)} · CPC title
containing sulfur as the only heteroatom · CPC title
not condensed with other rings · CPC title
Ortho-condensed systems · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.